共 69 条
Novel Optical Biosensor Based on a Nano-Gold Coated by Schiff Base Doped in Sol/Gel Matrix for Sensitive Screening of Oncomarker CA-125
被引:25
作者:
Abou-Omar, Mona N.
[1
]
Attia, Mohamed S.
[5
]
Afify, Hisham G.
[1
]
Amin, Mohammed A.
[2
]
Boukherroub, Rabah
[3
]
Mohamed, Ekram H.
[4
]
机构:
[1] Ain Shams Univ, Dept Chem, Fac Women Arts Sci & Educ, Cairo 13013, Egypt
[2] Taif Univ, Coll Sci, Dept Chem, At Taif 21944, Saudi Arabia
[3] Univ Polytech Hauts France, Univ Lille, CNRS, UMR 8520 IEMN,Cent Lille, F-59000 Lille, France
[4] British Univ Egypt, Fac Pharm, Pharmaceut Chem Dept, Cairo 11837, Egypt
[5] Ain Shams Univ, Fac Sci, Chem Dept, Cairo 11566, Egypt
来源:
关键词:
RESONANCE ENERGY-TRANSFER;
CA15-3;
TUMOR-MARKERS;
ELECTROCHEMICAL IMMUNOSENSOR;
IMPEDIMETRIC IMMUNOSENSOR;
EARLY-DIAGNOSIS;
OVARIAN-TUMORS;
GRAPHENE OXIDE;
CARBON DOTS;
IN-VITRO;
CA;
125;
D O I:
10.1021/acsomega.1c01974
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
The urge for sensitive, facile, minimally invasive, and fast detection method of CA-125, a significant and crucial biomarker in ovarian malignancy, is currently substantial. This paper describes the detailed construction and characterization of a newly designed optical nano-biosensor to detect CA-125 accurately and sensitively. The fabricated sensor consists of a nano-gold thin film doped into a matrix of sol-gel, exhibiting a centered fluorescence band at 423 nm when excited at 340 nm. The quantification of CA-125 relies on its quenching ability of this fluorescence signal. The sensor was challenged to evaluate its sensitivity and specificity in detecting CA-125 present in samples collected from ovarian cancer diagnosed patients and compared to samples from healthy women as a control. Our findings revealed that the developed biosensor had a sensitivity of 97.35% and a specificity of 94.29%. Additionally, a wide linearity range over 2.0-127.0 U mL(-1) for CA-125 was achieved with a detection limit of 1.45 U mL(-1). Furthermore, the sensor could successfully discriminate samples between healthy and diseased people, which demonstrates its suitability in CA-125 assessment.
引用
收藏
页码:20812 / 20821
页数:10
相关论文